Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations.

Published on Mar 24, 2021in Pharmaceutics4.421
· DOI :10.3390/PHARMACEUTICS13040437
Paola Mura50
Estimated H-index: 50
,
Francesca Maestrelli27
Estimated H-index: 27
+ 2 AuthorsMarzia Cirri33
Estimated H-index: 33
Sources
Abstract
The aim of this study was the optimization of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in terms of physicochemical and biopharmaceutical properties, to develop effective and stable aqueous liquid formulations of hydrochlorothiazide, suitable for paediatric therapy, overcoming its low-solubility and poor-stability problems. Based on solubility studies, Precirol® ATO5 and Transcutol® HP were used as solid and liquid lipids, respectively. The effect of different surfactants, also in different combinations and at different amounts, on particle size, homogeneity and surface-charge of nanoparticles was carefully investigated. The best formulations were selected for drug loading, and evaluated also for entrapment efficiency and release behaviour. For both SLN and NLC series, the use of Gelucire® 44/14 as surfactant rather than PluronicF68 or Tween® 80 yielded a marked particle size reduction (95–75 nm compared to around 600–400 nm), and an improvement in entrapment efficiency and drug release rate. NLC showed a better performance than SLN, reaching about 90% entrapped drug (vs. 80%) and more than 90% drug released after 300 min (vs. about 65%). All selected formulations showed good physical stability during 6-month storage at 4 °C, but a higher loss of encapsulated drug was found for SLNs (15%) than for NLCs (<5%). Moreover, all selected formulations revealed the absence of any cytotoxic effect, as assessed by a cell-viability test on Caco-2 cells and are able to pass the intestinal epithelium as suggested by Caco-2 uptake experiments.
References44
Newest
#1Sebastián Scioli Montoto (UNLP: National University of La Plata)H-Index: 4
#2Giuliana Muraca (UNLP: National University of La Plata)H-Index: 2
Last. María Esperanza Ruiz (UNLP: National University of La Plata)H-Index: 10
view all 3 authors...
In the golden age of pharmaceutical nanocarriers, we are witnessing a maturation stage of the original concepts and ideas. There is no doubt that nanoformulations are extremely valuable tools for drug delivery applications; the current challenge is how to optimize them to ensure that they are safe, effective and scalable, so that they can be manufactured at an industrial level and advance to clinical use. In this context, lipid nanoparticles have gained ground, since they are generally regarded ...
11 CitationsSource
#1Julia ZahnH-Index: 1
#2André HoerningH-Index: 12
Last. Antje NeubertH-Index: 27
view all 5 authors...
Pharmacotherapy in children requires medicinal products in age-appropriate dosage forms and flexible dose strengths. Healthcare professionals often encounter a lack of licensed and commercially available formulations, which results in the need for manipulation. This study aimed to investigate the nature, frequency and preventability of the manipulation of medicinal products before oral drug administration to paediatric inpatients in Germany. A prospective, direct observational approach was used....
2 CitationsSource
#1Marzia Cirri (UniFI: University of Florence)H-Index: 33
#2Francesca Maestrelli (UniFI: University of Florence)H-Index: 27
Last. Lorenzo Di Cesare Mannelli (UniFI: University of Florence)H-Index: 36
view all 5 authors...
The development of specific and age-appropriate pediatric formulations is essential to assure that all children and their care-givers can easily access to safe and effective dosage forms. The need for developing specific pediatric medicinal products has been highlighted by the European Medicines Agency. The aim of this study was to investigate the effectiveness of combining the advantages of both cyclodextrin (CD) complexation and loading into nanostructured lipid carriers (NLC), to obtain a liq...
7 CitationsSource
#1Marzia Cirri (UniFI: University of Florence)H-Index: 33
#2Lavinia MaestriniH-Index: 1
Last. Lorenzo Di Cesare Mannelli (UniFI: University of Florence)H-Index: 36
view all 7 authors...
AbstractThe hydrochlorothiazide (HCT) low solubility and permeability give rise to limited and variable bioavailability; its low stability makes it difficult to develop stable aqueous liquid formulations; its low dose makes the achievement of a homogeneous drug distribution very difficult. Thus, the aim of this study was to investigate the effectiveness of a strategy based on the development of nanostructured lipid carriers (NLC) as an innovative oral pediatric formulation of HCT with improved t...
34 CitationsSource
#2Helle HolstH-Index: 10
Last. Karel Allegaert (Katholieke Universiteit Leuven)H-Index: 48
view all 3 authors...
To attain effective and safe pharmacotherapy, formulations in (pre)term neonates should enable extensive dose flexibility. During product development and subsequent authorization and clinical use of such formulations, there is also a need for informed decisions on excipient exposure: in addition to the need to improve the knowledge on active compounds, there is a similar need to improve the knowledge on excipients in neonates. Excipients are added to formulations as co-solvent, surfactant, prese...
15 CitationsSource
#1Archana Khosa (BITS: Birla Institute of Technology and Science)H-Index: 4
#2Satish Reddi (BITS: Birla Institute of Technology and Science)H-Index: 4
Last. Ranendra N. Saha (BITS: Birla Institute of Technology and Science)H-Index: 19
view all 3 authors...
Abstract Nanostructured lipid carriers (NLC), comprises of a blend of solid and liquid lipids which results in a partially crystallized lipid system and imparts many advantages over solid lipid nanoparticles such as enhanced drug loading capacity, drug release modulation flexibility and improved stability. NLC have found numerous applications in both pharmaceutical and cosmetic industry due to ease of preparation, the feasibility of scale-up, biocompatibility, non-toxicity, enhanced targeting ef...
99 CitationsSource
#2Ch. Niranjan PatraH-Index: 9
Last. Manoranjan Sahu (Berhampur University)H-Index: 1
view all 7 authors...
Abstract Poly ethylene glycol (PEG) ester surfactants are synthesized by reacting polyethylene glycol with fatty acid. The polyethylene glycol comprises the hydrophilic part of the surfactant and the fatty acid is the lipophilic part. By varying the molecular weight of the PEG and the fatty acid, surfactants covering wide range of hydrophilic lipophilic balance (HLB) values can be produced. Gelucire is the family of vehicle derived from mixtures of mono, di and triglycerides with PEG esters of f...
16 CitationsSource
#1Marzia Cirri (UniFI: University of Florence)H-Index: 33
#2Natascia Mennini (UniFI: University of Florence)H-Index: 24
Last. Lorenzo Di Cesare Mannelli (UniFI: University of Florence)H-Index: 36
view all 6 authors...
Abstract An innovative pediatric oral formulation of hydrochlorothiazide (HCT) (2 mg/mL), endowed with improved bioavailability and sustained release properties and suitable for the hypertension treatment in pediatric patients, was developed by combining the drug-cyclodextrin complexation and the incorporation of the complex into Solid Lipid Nanoparticles (SLN). Precirol ® ATO5-based SLN, with two different surfactants (Pluronic ® F68 and Tween ® 80) loaded with the drug as such or as binary sys...
21 CitationsSource
#1Diana P. Gaspar (University of Lisbon)H-Index: 5
#2Vasco Faria (University of Lisbon)H-Index: 2
Last. António J. Almeida (University of Lisbon)H-Index: 31
view all 6 authors...
Abstract Systemic administration of antitubercular drugs can be complicated by off-target toxicity to cells and tissues that are not infected by Mycobacterium tuberculosis . Delivery of antitubercular drugs via nanoparticles directly to the infected cells has the potential to maximize efficacy and minimize toxicity. The present work demonstrates the potential of solid lipid nanoparticles (SLN) as a delivery platform for rifabutin (RFB). Two different RFB-containing SLN formulations were produced...
57 CitationsSource
#1Ana Beloqui (UCL: Université catholique de Louvain)H-Index: 16
#2María Ángeles Solinís (UPV/EHU: University of the Basque Country)H-Index: 24
Last. Véronique Préat (UCL: Université catholique de Louvain)H-Index: 64
view all 5 authors...
Abstract During the past decade, the number of studies describing nanostructured lipid carriers (NLCs)-based formulations has been dramatically increased. The raise in NLC exploitation is essentially due to defeated barriers within the technological process of lipid-based nanoparticles' formulation and increased knowledge of the underlying mechanisms of transport of NLCs via different routes of administration. This review article aims to give an overview on the current state of the art of NLC as...
268 CitationsSource
Cited By0
Newest
This review aims to provide the state of the art on polymeric and lipid nanoparticles, used or suggested to approach pediatric diseases’ problems and needs, and to inspire new researches in this field. Several drugs are currently not available in formulations suitable for pediatric patients. The United States Pediatric Formulation Initiative suggested applying new technologies to pediatric drug formulations, for instance, nanotechnology. The literature analysis showed that polymeric and lipid na...
Source